Skip to main content
. 2019 May 28;49(6):469–484. doi: 10.4070/kcj.2019.0136

Figure 1. Number of patients of Asian patients by region enrolled in PARADIGM-HF (Asian race only).

Figure 1

PARADIGM-HF = Prospective comparison of Angiotensin Receptor-neprilysin inhibitor with Angiotensin converting enzyme inhibitor to Determine Impact on Global Mortality and Morbidity in Heart Failure trial.